Register
Register
Register

Project cooperationUpdated on 6 January 2026

Academic multi-centre clinical trial partnership with Canada

Clinician Scientist at Queen's University

Kingston, Canada

About

The Canadian Cancer Trials Group (CCTG) is an academic cooperative oncology group that designs and conducts clinical trials testing cancer therapy, supportive care and prevention interventions across Canada. The Group is a collaborative network of researchers, physicians, scientists, statisticians and patients internationally recognized for finding the treatments that give people with cancer longer, better quality lives.

Created in 1980, the group has run trials resulting in major, life-saving breakthroughs in breast, colorectal, blood, lung, ovarian, brain and prostate cancer. The network is made of more than 85 member institutions, comprising over 2,100 Canadian investigators working with 4,400 clinical trial staff and has facilitated over 600 trials. Globally, CCTG has worked with more than 20,000 collaborators and clinical trial professionals in 40 countries on 6 continents. Most importantly are the approximately 3,000 patient volunteers per year who participate in our trials in order to potentially receive better treatments that could also benefit others in the future.

CCTG’s Operations and Statistics Centre is located in the Sinclair Cancer Research Institute at Queen’s University, with in-house faculty researchers that include clinician scientists, researchers in community health and epidemiology, and biostatisticians.

The group is proud to be one of the national programmes of the Canadian Cancer Society (CCS), the only non-American partner of the US National Clinical Trials Network and collaborators with research cooperative groups around the world. These international partnerships are central to the success of their cancer clinical trials and crucial to the advancement of the cancer research agenda in Canada.

https://www.ctg.queensu.ca/

Stage

  • Ideation - identifying the project idea

Topic

  • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Organisation

Queen's University

University

Kingston, Canada

Similar opportunities

  • Project cooperation

    Facilitating contacts with cancer researchers at Medical University of Vienna

    • Completing the consortia
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Reinhard Eckert

    Research Service at Medical University of Vienna

    Vienna, Austria

  • Project cooperation

    Mission Cancer

    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Lidia Castro

    Pre-award project manager at Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

    Barcelona, Spain

  • Project cooperation

    Lund-Kyiv Cancer Collaboration

    • Consortium/Coordinator seeks Partners
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine

    Mats Jerkeman

    Professor at Lund University

    Lund, Sweden